On the medicinal chemistry of gold complexes as anticancer drugs

Ingo Ott(Technische Universität Braunschweig)

Coordination Chemistry Reviews

February 28, 2009

10.1016/j.ccr.2009.02.019

Cited by 811

Abstract

Related Papers

Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

Barnett Rosenberg, Loretta Van Camp, Thomas Krigas|Nature|1965|3k

Mitochondria-Targeted Chemotherapeutics: The Rational Design of Gold(I) <i>N</i>-Heterocyclic Carbene Complexes That Are Selectively Toxic to Cancer Cells and Target Protein Selenols in Preference to Thiols

James L. Hickey, Rasha A. Ruhayel, Peter J. Barnard et al.|Journal of the American Chemical Society|2008|583

Thioredoxin reductase as a pathophysiological factor and drug target

Katja Becker, Stephan Gromer, R. Heiner Schirmer et al.|European Journal of Biochemistry|2000|387

Gold derivatives for the treatment of cancer

Edward R. T. Tiekink|Critical Reviews in Oncology/Hematology|2002|292

Gold(iii) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cellsElectronic supplementary information (ESI) available: Further experimental and crystallographic details. See http://www.rsc.org/suppdata/cc/b3/b303294a/

Chi‐Ming Che, Raymond Wai‐Yin Sun, Wing‐Yiu Yu et al.|Chemical Communications|2003|276